why choose us

First received: December 25, 2022

Clinical Trial: E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cervical Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase II Trial of T Cell Receptor Gene Therapy Targeting Human Papillomavirus ( HPV) 16 E7 for HPV-Associated Cancers

Brief Summary: This is a phase II clinical trial to assess the clinical activity of immunotherapy with E7 TCR-T cells for metastatic HPV-associated cancers.HPV-associated cancers in include cervical, throat, penile, vulvar, vaginal, anal, and other cancers.Participants will receive a conditioning regimen, E7 TCR-T cells, and aldesleukin.Clinical response to treatment will be determined.

Read more